A thrombocytosis occurring in Philadelphia positive CML in molecular response to imatinib can reveal an underlying JAK2V617F myeloproliferative neoplasm
L. Véronèse, A. Tchirkov, C. Richard-Pebrel, A. Ledoux-Pilon, J. Fleury, C. Chaleteix, C. Goumy, L. Gouas, M.G. Berger, P. Vago, J.O. Bay, O. TournilhacVolume:
34
Year:
2010
Language:
english
Pages:
1
DOI:
10.1016/j.leukres.2009.09.025
File:
PDF, 109 KB
english, 2010